The Readout LOUD Damian Garde and Meg Tirrell Listen: Messy PBM conflicts, debatable vaccines, & the future of flu season
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Biogen’s messy board, Laronde’s data problem, & the downside of a boom
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Fake medical devices, real cancer drugs, & curious Ozempic effects
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos’ turnaround
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Lilly’s Alzheimer’s success, a milestone FDA approval, & Moderna’s shrinking business
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Explaining the E.U.’s pharma overhaul, Lilly’s booming business, & a long-awaited drug approval
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Sarepta’s pivotal moment, biotech’s big week, & the future of Covid boosters
The Readout LOUD Damian Garde and Meg Tirrell Listen: How the legal battle over abortion could thwart research, plus: the FDA ‘bully pulpit’ and Moderna’s future
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Biotech’s monkey shortage, the broken generics market, & conference cancel culture
The Readout LOUD Damian Garde and Meg Tirrell Listen: Bancel v. Bernie, Sarepta’s FDA runaround, & Regeneron’s ever-growing blockbuster
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: SVB’s long biotech shadow, pushy AI algorithms, & Icahn v. Illumina
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Robert Califf on how drugs get approved, plus the nascent revolution in obesity
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: The next CRISPR fight, cheaper insulin, & an FDA shuffle
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Vertex vs. insurers, Moderna’s future, & biotech’s long winter
The Readout LOUD Meg Tirrell, Adam Feuerstein, and Damian Garde STAT Plus: Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and much more
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Vas Narasimhan on the future of pharma, plus Moderna’s vaccine promise & a biotech presidential bid
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: The return of bird flu and the effects of pandemic fatigue
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: Pharma blockbusters, pandemic policy, & legal chicanery
The Readout LOUD Adam Feuerstein and Meg Tirrell Listen: George Scangos’ retirement, annual Covid vaccines, an Alzheimer’s drug rejection
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: How blockbusters get made, new vaccines for RSV, and mRNA’s Q score
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein #JPM23 in review, the year ahead, & the merits of Miami
The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein Listen: #JPM23, the future of Alzheimer’s, & rising Covid variants
The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein Listen: Leaky health data, ASH22, & what it takes to get booed by your peers
The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein The ‘electric vehicles’ of pharma, Illumina’s boondoggle, & a Theranos sentencing